Lipase maturation factor 1: Its expression in Zucker diabetic rats, and effects of metformin and fenofibrate

Diabetes and Metabolism

Volumn 35, Issue 6, 2009, Pages 452-457

  Forcheron, F ^a   Basset, A ^a   Del Carmine, P ^a   Beylot, M ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Diabetes; LMF1; PPAR ; Rat; Triglycerides

Indexed keywords

FENOFIBRATE; GLUCOSE; LIPASE MATURATION FACTOR 1; MESSENGER RNA; METFORMIN; PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HEART; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MUSCLE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, NONESTERIFIED; HEART; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MEMBRANE PROTEINS; METFORMIN; MYOCARDIUM; OBESITY; PROCETOFEN; RATS; RATS, ZUCKER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIGLYCERIDES;

EID: 71149095260     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2009.05.004     Document Type: Article

References (17)

1. Hokanson J., and Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population based prospective studies. J Cardiovasc Risk 3 (1996) 213-219
2. Ben-Zeev O., Mao H.Z., and Doolittle M.H. Maturation of lipoprotein lipase in the endoplasmic reticulum. Concurrent formation of functional dimers and inactive aggregates. J Biol Chem 277 (2002) 10727-10738
3. Braun J.E., and Severson D.L. Regulation of the synthesis, processing and translocation of LPL. Biochem J 287 (1992) 337-347
4. Peterfy M., Ben-Zeev O., Mao H.Z., Weissglas-Volkov D., Aouizerat B.E., Pullinger C.R., et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat Genet 39 (2007) 1483-1487
5. Heller F., and Harvengt C. Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipidaemic subjects. Eur J Clin Pharmacol 23 (1983) 57-63
6. Zhou G., Myers R., and Li Y. Role of AMP activated protein kinase in mechanism of metformin action. J Clin Invest 108 (2001) 1167-1174
7. Forcheron F., Cachefo A., Thevenon S., Pinteur C., and Beylot M. Mechanisms of the triglyceride and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients. Diabetes 51 (2002) 3486-3491
8. Etgen G., and Oldham B. Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. Metabolism 49 (2000) 684-688
9. Smith A.C., Mullen K.L., Junkin K.A., Nickerson J., Chabowski A., Bonen A., et al. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia. Am J Physiol 293 (2007) E172-E181
10. Sreenan S., Sturis J., Pugh W., Burant C., and Polonsky K. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am J Physiol 34 (1996) E742-E747
11. Chirieac D.V., Collins H.L., Cianci J., Sparks J.D., and Sparks C.E. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats. Am J Physiol 287 1 (2004) E42-E49
12. Zang M.Z.A., Hou X., Nagata D., Walsh K., Herscovitz H., Brecher P., et al. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 279 (2004) 47898-47905
13. Lefebvre P., Chinetti G., Fruchart J., and Staels B. Sorting out the roles of PPARα in energy metabolism and vascular homeostasis. J Clin Invest 116 (2006) 571-580
14. Motojima K., Passilly P., Peters J.M., Gonzalez F.J., and Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 273 (1998) 16710-16714
15. Schoonjans K.P.-O.J., Lefebvre A.M., Heyman R.A., Briggs M., Deeb S., Staels B., et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15 (1996) 5336-5348
16. Auwerx J., Schoonjans K., Fruchart J., and Staels B. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have disctinct effects. J Atheroscler Thromb 3 (1996) 80-89
17. Ranganathan G., Unal R., Pokrovskaya I., Yao-Borengasser A., Phanavanh B., Lecka-Czernik B., et al. The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 47 (2006) 2444-2450